HHS Stock — Harte Hanks Inc

Harte Hanks Inc (HHS)

Updated October 16, 2026.

HHS is a Stock. Total return is -82.1% over the past 32.9 years, 2968.7 points behind SPY at 2886.6%.

Harte Hanks Inc is an operating company in the equity asset class. The company does not currently distribute to shareholders. This security may appeal to investors seeking capital appreciation rather than income.

HHS performance versus SPY

Price and return data through 2026-10-16.

Total return is -82.1% over the past 32.9 years, 2968.7 points behind SPY at 2886.6%. Over the past year its total return — price change plus distributions reinvested — is 19.8%. Its deepest 1-year drawdown was 48.8%.

HHS key facts

Asset type

Stock

Asset class

Equity

Inception date

11/04/1993

Distribution frequency

None

5-year average yield

5.9

Last close

$4.29 (as of 2026-10-16)

Market cap

$31,978,690

Average volume

2708.0

Ex-dividend date

02/26/2016

Payment date

03/15/2016

Beta

0.174

Payout ratio

0.0%

Forward P/E

14.2857

EPS

$-0.77

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

HHS risks and drawbacks

Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 48.8%.

Who may consider HHS — and who may not

It is a weaker fit for investors who need monthly cash flow (HHS does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on HHS

• All tickers starting with H

Tagged: Industrials.

Frequently asked questions